Menu
Washingtoner
  • Home
  • Health
  • Boeing
  • Daryl Guberman
  • Aerospace
  • Technology
  • Business
  • Lifestyle
  • ANSI-ANAB
Washingtoner

FreezeNit Announces Exclusive Licensing of Novel Non-Toxic Lice Treatment Technology
Washingtoner/10287890

Trending...
  • Applicants Sought for the Tacoma Creates Advisory Board
  • KLEKT Announces Appointment of Jay Kimpton to Board of Directors
  • Tacoma City Council Restricts Unauthorized Use of Public Property for Civil Immigration Enforcement
FreezeNit
Naturally-Derived OTC Gel Eliminates Lice Without Neurotoxins, Launching Spring 2025

MARBLEHEAD, Mass. - Washingtoner -- FreezeNit, a leader in innovative lice treatment solutions, is thrilled to announce the exclusive licensing of a novel over-the-counter (OTC) lice treatment gel designed to provide a safe, naturally-derived, and highly effective alternative to traditional synthetic or pesticide-based lice treatments.

Unlike conventional OTC lice treatments that rely on pesticide-based pyrethroids, which have decreasing efficacy due to lice resistance, this new technology works by a purely mechanical method of action to eliminate lice and their eggs. The patented formula is free from harsh chemicals and instead leverages natural abrasives, such as diatomaceous earth and walnut shell powder, orange oil extract, and conditioning agents to physically shred lice and nits, while being gentle on the hair and scalp.

This addition strengthens FreezeNit's growing product portfolio, reinforcing the company's mission to provide clean, effective, science-backed treatments that parents can trust.

"This is an incredibly exciting milestone for FreezeNit," said Joanna Shu, CEO of FreezeNit. "By securing exclusive rights to this novel technology, we're positioned to be on the cutting edge of first aid treatments that are gentle on kids. Traditional lice treatments have failed parents and kids, but with this gel, lice don't stand a chance."

More on Washingtoner
  • T. Jones Group's Cameron Jones Serves as Judge for the 2026 CHBA National Awards for Housing Excellence
  • Derek Advanced Tracking Systems Revolutionizes Asset Monitoring with Advanced Technology
  • The AI Direction Deficit: TripleTen Study Finds Staff Get Told to Use AI — But Not Trained to Use It
  • Spokane: Flags Lowered for Peace Officers Memorial Day
  • $29.8 Million Record Setting Q1 with Boosted Annual Guidance to $160 Million for Expanding Pre-Owned Boat Dealer: Off The Hook YS, Inc. N Y S E: OTH

✔ Clinically Proven – was shown to be 96% effective in a clinical trial.
✔ No Resistance Issues – Unlike permethrin-based treatments, which have seen increased lice resistance, this technology works mechanically—not chemically—so lice cannot develop immunity.
✔ Patented & Protected – This novel formula and method of action is patented in the U.S., Canada, and the EU, ensuring exclusivity in the market.
✔ Class I, 510(k) Exempt – The FDA-regulated status allows for a fast-tracked market entry.

FreezeNit is actively engaging with retailers, distributors, and healthcare providers to bring this breakthrough lice treatment to families everywhere.

FreezeNit is an innovative healthcare company dedicated to revolutionizing first-aid with safe, effective, and science-backed solutions. By leveraging cutting-edge technology and natural alternatives to neurotoxins, FreezeNit provides families with fast, reliable, and pesticide-free treatments for head lice infestations.  For more information, visit www.FreezeNit.com.

Media Contact
Cathy Henry
cathy@freezenit.com
214-924-5992


Source: FreezeNit

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • SRK Collective Media Group Launches with a Modern Approach to Media, Authority Building, and Cultural Visibility
  • MSBG Corporation Acquires GridWatch US Telemetry Automation System
  • TAYP Expands Athlete Exposure Platform Beyond Georgia With New Push Into Virginia and the 757
  • KT Medical Staffing Expands Concierge Nursing and Private Duty Nursing Services in Orange County
  • The Millennium Alliance Achieves Great Place To Work® Certification™ Amid Continued Growth
  • The Millennium Alliance Appoints Former Adweek Executive Eric Hayden Shakun as Chief Financial Officer to Accelerate Next Phase of Growth
  • North Puget Sound League Launches New Player Development Academy (PDA) Tryouts
  • T. Jones Group Named Finalist Across Multiple Categories at the 2026 Georgie Awards
  • The Simplest Small Business You're Probably Not Thinking About
  • San Francisco Writer Wins Webby Award, Internet's Highest Honor, for Website Based on her Novel
  • EDC Weekend Comedy Special Featuring Don Barnhart & Friends — Use Promo Code FRIEND for 50% Off
  • N Y S E: OTH Off The Hook YS Is Building a Vertically Integrated Marine Empire — And Investors Are Starting to Notice
  • Concierge Title Agency Merges with Independence Title, Inc. to Deliver an Expanded Concierge Closing Experience Across South Florida
  • Grow My Security Company Launches Next-Generation Website and Expands Strategic Marketing Solutions for the Security Industry
  • $4.8M in Contracted AI Revenue with Projections of $30M Over 6-12 Months for Diversified AI Software and Platform-Based Services Provider XMax Inc
  • Michelangelo's Great Secret Hiding in Plain Sight
  • Longevity Academy Launches The Longevity Leaders Project with Interview of Respira Global CEO
  • From Blank Page to Published Book
  • Virginia Marchese's Paradox: A Nation Still Deciding Who Belongs Examines Race, Migration, Law, and America's Unfinished Struggle for Equality
  • Larry R. Wasion's Jump Gate III RoadMaker Blends Cutting-Edge Sci-Fi with High-Stakes Space Exploration and Complex Technologies
_catLbl0 _catLbl1

Popular on Washingtoner

  • Altruvest and Financial Executives International Canada Announce Strategic Partnership to Strengthen Nonprofit Boards Across Canada
  • Freedomtech Solutions creates 'Global Data Centre Network (IDCN)'
  • Virginia Moving Company Nearly Doubles Customer Calls in Two Weeks After Switching to CARL — the Bold New Alternative to WordPress
  • Umbrella Becomes First FinOps Platform to Support AWS Billing Transfer Onboarding
  • New Report Reveals Plane Crashes Are Not Where You'd Think
  • L2 Aviation Acquires Advance Aero
  • Axencis Launches Performance Partnership for Brand Protection
  • City Council Adopts Updated Resolution for ‘Connect Tacoma’ Ballot Proposition
  • Tacoma: Pothole Palooza Returns May 4 – 15 to Focus on Maintenance and Preservation of 10 Arterial Roadways
  • Project Pretzel Introduces a New System for Running Renovation Projects with Built In Contracts and Real Time Execution

Similar on Washingtoner

  • Collectibles EvoRelic Celebrates Stellar 4.8-Star Customer Rating
  • Pediatrician Launches "Confessions of a Detective Doctor" Children's Book Series
  • All About Technology Celebrates 25 Years of Bridging Detroit's Digital Divide
  • iatroX surpasses 500,000 clinical queries and expands specialist exam coverage
  • KT Medical Staffing Expands Concierge Nursing and Private Duty Nursing Services in Orange County
  • $4.8M in Contracted AI Revenue with Projections of $30M Over 6-12 Months for Diversified AI Software and Platform-Based Services Provider XMax Inc
  • Longevity Academy Launches The Longevity Leaders Project with Interview of Respira Global CEO
  • American Mensa and Davidson Institute Join Forces To Strengthen Support for Profoundly Gifted Youth
  • Mensa Foundation Event Reframes Brain Health for Every Age
  • With a Dream and a Team, Monalisa Okojie Is Empowering the Next Generation Through EXPOSE NGO
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute